663 related articles for article (PubMed ID: 2886217)
1. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
[TBL] [Abstract][Full Text] [Related]
3. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
4. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry.
Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW
Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553
[TBL] [Abstract][Full Text] [Related]
5. Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis.
Bolton MG; Muñoz A; Jacobson LP; Groopman JD; Maxuitenko YY; Roebuck BD; Kensler TW
Cancer Res; 1993 Aug; 53(15):3499-504. PubMed ID: 8339253
[TBL] [Abstract][Full Text] [Related]
6. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
7. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz.
Roebuck BD; Curphey TJ; Li Y; Baumgartner KJ; Bodreddigari S; Yan J; Gange SJ; Kensler TW; Sutter TR
Carcinogenesis; 2003 Dec; 24(12):1919-28. PubMed ID: 14555609
[TBL] [Abstract][Full Text] [Related]
9. Protection by 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) against the hepatotoxicity of aflatoxin B1 in the rat.
Liu YL; Roebuck BD; Yager JD; Groopman JD; Kensler TW
Toxicol Appl Pharmacol; 1988 May; 93(3):442-51. PubMed ID: 3130679
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Davidson NE; Egner PA; Kensler TW
Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the post-initiation effects of oltipraz on aflatoxin B1-induced preneoplastic foci in a rat model of hepatic tumorigenesis.
Maxuitenko YY; MacMillan DL; Kensler TW; Roebuck BD
Carcinogenesis; 1993 Nov; 14(11):2423-5. PubMed ID: 8242875
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
Scholl P; Musser SM; Kensler TW; Groopman JD
Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
[TBL] [Abstract][Full Text] [Related]
13. Modification of aflatoxin B1 binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione.
Kensler TW; Egner PA; Trush MA; Bueding E; Groopman JD
Carcinogenesis; 1985 May; 6(5):759-63. PubMed ID: 3924431
[TBL] [Abstract][Full Text] [Related]
14. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
[TBL] [Abstract][Full Text] [Related]
15. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
Stresser DM; Bailey GS; Williams DE
Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
[TBL] [Abstract][Full Text] [Related]
16. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats.
Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS
Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412
[TBL] [Abstract][Full Text] [Related]
17. Effect of high and low dietary protein on the dosing and postdosing periods of aflatoxin B1-induced hepatic preneoplastic lesion development in the rat.
Appleton BS; Campbell TC
Cancer Res; 1983 May; 43(5):2150-4. PubMed ID: 6131741
[TBL] [Abstract][Full Text] [Related]
18. Effect of butylated hydroxyanisole pretreatment on aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in isolated hepatocytes from rats.
Jhee EC; Ho LL; Tsuji K; Gopalan P; Lotlikar PD
Cancer Res; 1989 Mar; 49(6):1357-60. PubMed ID: 2493978
[TBL] [Abstract][Full Text] [Related]
19. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
Jhee EC; Ho LL; Lotlikar PD
Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
[TBL] [Abstract][Full Text] [Related]
20. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones.
Kwak MK; Egner PA; Dolan PM; Ramos-Gomez M; Groopman JD; Itoh K; Yamamoto M; Kensler TW
Mutat Res; 2001 Sep; 480-481():305-15. PubMed ID: 11506823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]